175 related articles for article (PubMed ID: 28107674)
1. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
[TBL] [Abstract][Full Text] [Related]
2. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
Ji L; Tang Y; Pang X; Zhang Y
Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
[TBL] [Abstract][Full Text] [Related]
5. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
Shi H; Fang X; Li Y; Zhang Y
Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas.
Wu M; Wanggou S; Li X; Liu Q; Xie Y
Onco Targets Ther; 2017; 10():3781-3788. PubMed ID: 28794642
[TBL] [Abstract][Full Text] [Related]
7. Cancer proteome and metabolite changes linked to SHMT2.
Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
[TBL] [Abstract][Full Text] [Related]
8. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.
Kim D; Fiske BP; Birsoy K; Freinkman E; Kami K; Possemato RL; Chudnovsky Y; Pacold ME; Chen WW; Cantor JR; Shelton LM; Gui DY; Kwon M; Ramkissoon SH; Ligon KL; Kang SW; Snuderl M; Vander Heiden MG; Sabatini DM
Nature; 2015 Apr; 520(7547):363-7. PubMed ID: 25855294
[TBL] [Abstract][Full Text] [Related]
9. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
[TBL] [Abstract][Full Text] [Related]
10. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
[TBL] [Abstract][Full Text] [Related]
11. FGF2 as a potential prognostic biomarker for proneural glioma patients.
Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
[TBL] [Abstract][Full Text] [Related]
12. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of tissue microRNA10b may help predict glioma prognosis.
Zhang X; Cheng J; Fu L; Li Q
J Clin Neurosci; 2016 Jul; 29():59-63. PubMed ID: 26988656
[TBL] [Abstract][Full Text] [Related]
14. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
[TBL] [Abstract][Full Text] [Related]
15. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
16. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade.
Yin K
Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742
[TBL] [Abstract][Full Text] [Related]
17. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR
Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis.
Yang J; Liao D; Wang Z; Liu F; Wu G
J Surg Res; 2011 Jun; 168(1):97-102. PubMed ID: 20036387
[TBL] [Abstract][Full Text] [Related]
20. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.
Xie M; Pei DS
Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
